Hyperhidrosis: Clinical presentation, evaluation and management

Expert Review of Dermatology

Volumn 5, Issue 1, 2010, Pages 31-44

  Schieman, Colin ^a   Gelfand, Gary J ^a   Grondin, Sean C ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Botulinum toxin; Compensatory sweating; Hyperhidrosis; Surgery; Sympathectomy

Indexed keywords

ALDEHYDE; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ALUMINUM CHLORIDE; ANESTHETIC AGENT; ANTICONVULSIVE AGENT; ANTIPERSPIRANT AGENT; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BOTULINUM TOXIN; BOTULINUM TOXIN A; CALCIUM CHANNEL BLOCKING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; GLYCOPYRRONIUM BROMIDE; NONSTEROID ANTIINFLAMMATORY AGENT; OXYBUTYNIN; PLACEBO; SPASMOLYTIC AGENT;

ANAMNESIS; BLURRED VISION; CLINICAL EVALUATION; CLINICAL FEATURE; COMORBIDITY; CONSERVATIVE TREATMENT; CONSTIPATION; DIAGNOSTIC TEST; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; DRUG WITHDRAWAL; HUMAN; HYPERHIDROSIS; IONTOPHORESIS; LABORATORY TEST; ORTHOSTATIC HYPOTENSION; PATHOPHYSIOLOGY; PATIENT SELECTION; PHYSICAL EXAMINATION; POSTOPERATIVE COMPLICATION; PREVALENCE; PRIORITY JOURNAL; PSYCHOTHERAPY; RECOMMENDED DRUG DOSE; REVIEW; SEDATION; SIDE EFFECT; SKIN IRRITATION; SURGICAL TECHNIQUE; SYMPATHECTOMY; SYMPATHETIC INNERVATION; TACHYCARDIA; THORACOTOMY; URINE RETENTION; XEROSTOMIA;

EID: 77951648798     PISSN: 17469872     EISSN: None     Source Type: Journal    
DOI: 10.1586/edm.09.61     Document Type: Review

References (70)

1. Shargall Y, Spratt E, Zeldin RA. Hyperhidrosis: what is it and why does it occur? Thorac. Surg. Clin. 18(2), 125-132 (2008).
2. Solish N, Wang R, Murray CA. Evaluating the patient presenting with hyperhidrosis. Thorac. Surg. Clin. 18(2), 133-140 (2008).
3. Amir M, Arish A, Weinstein Y, Pfeffer M, Levy Y Impairment in quality of life among patients seeking surgery for hyperhidrosis (excessive sweating): preliminary results. Isr. J. Psychiatry Relat. Sci. 37(1), 25-31 (2000).
4. Strutton DR, Kowalski J W, Glaser DA, Stang PE. US prevalence of hyperhidrosis and impact on individuals with axillary hyperhidrosis: results from a national survey. J. Am. Acad. Dermatol. 51(2), 241-248 (2004).
5. Cina CS, Clase CM. The Illness Intrusiveness Rating Scale: a measure of severity in individuals with hyperhidrosis. Qual. Life Res. 8(8), 693-698 (1999).
6. Solish N, Benohanian A, Kowalski J W. Prospective open-label study of botulinum toxin type A in patients with axillary hyperhidrosis: effects on functional impairment and quality of life. Dermatol. Surg. 31(4), 405-413 (2005).
7. Ro KM, Cantor RM, Lange KL, Ahn SS. Palmar hyperhidrosis: evidence of genetic transmission. J. Vasc. Surg. 35(2), 382-386 (2002).
8. Higashimoto I, Yoshiura K, Hirakawa N et al. Primary palmar hyperhidrosis locus maps to 14q11.2-q13. Am. J. Med. Genet. A. 140(6), 567-572 (2006).
9. Hornberger J, Grimes K, Naumann M et al. Recognition, diagnosis, and treatment of primary focal hyperhidrosis. J. Am. Acad. Dermatol. 51(2), 274-286 (2004).
10. Smith CC. Idiopathic Hyperhidrosis. In: Up To Date. Basow DS (Ed). UpToDate, Waltham, MA, USA (2008).
11. Scrivener Y, Cribier B. [Morphology of sweat glands]. Morphologie 86(272), 5-17 (2002).
12. Kreyden OP, Scheidegger EP. Anatomy of the sweat glands, pharmacology of botulinum toxin, and distinctive syndromes associated with hyperhidrosis. Clin. Dermatol. 22(1), 40-44 (2004).
13. Bovell DL, Clunes MT, Elder HY, Milsom J, Jenkinson DM. Ultrastructure of the hyperhidrotic eccrine sweat gland. Br. J. Dermatol. 145(2), 298-301 (2001).
14. Atkins JL and Butler PE. Hyperhidrosis: a review of current management. Plast. Reconstr. Surg. 110(1), 222-228 (2002)
15. Schiller Y The anatomy and physiology of the sympathetic innervation to the upper limbs. Clin. Auton. Res. 13(Suppl. 1) I2-I5 (2003).
16. Gee S, Yamauchi PS. Nonsurgical management of hyperhidrosis. Thorac. Surg. Clin. 18(2), 141-155 (2008).
17. Solish N, Bertucci V, Dansereau A et al A comprehensive approach to the recognition, diagnosis, and severity-based treatment of focal hyperhidrosis: recommendations of the Canadian Hyperhidrosis Advisory Committee. Dermatol. Surg. 33(8), 908-923 (2007).
18. Connolly M, de Berker D. Management of primary hyperhidrosis: a summary of the different treatment modalities. Am. J. Clin. Dermatol. 4(10), 681-697 (2003).
19. Shaw JE, Abbott CA, Tindle K, Hollis S, Boulton AJ. A randomized controlled trial of topical glycopyrrolate, the frst specifc treatment for diabetic gustatory sweating. Diabetologia 40(3), 299-301 (1997).
20. Holzle E, Braun-Falco O. Structural changes in axillary eccrine glands following long-term treatment with aluminium chloride hexahydrate solution. Br. J. Dermatol. 110(4), 399-403 (1984).
21. Benohanian A, Boudjikanian A, Paylan Y Palmar and plantar hyperhidrosis: a practical management algorithm. Therapy 4(3), 279-283 (2007).
22. Sato K, Kang WH, Saga K, Sato KT. Biology of sweat glands and their disorders. I. Normal sweat gland function. J. Am. Acad. Dermatol. 20(4), 537-563 (1989). (Pubitemid 19091250)
23. Benohanian A, Dansereau A, Bolduc C, Bloom E. Localized hyperhidrosis treated with aluminum chloride in a salicylic acid gel base. Int. J. Dermatol. 37(9), 701-703 (1998).
24. + is critical for inhibition of palmar sweating by iontophoresis in water. J. Appl. Physiol. 75(5), 2258-2264 (1993).
25. Stolman LP. Treatment of excess sweating of the palms by iontophoresis. Arch. Dermatol. 123(7), 893-896 (1987).
26. Karakoc Y, Aydemir EH, Kalkan MT, Unal G. Safe control of palmoplantar hyperhidrosis with direct electrical current. Int. J. Dermatol. 41(9), 602-605 (2002).
27. Akins DL, Meisenheimer JL, Dobson RL. Effcacy of the Drionic unit in the treatment of hyperhidrosis. J. Am. Acad. Dermatol. 16(4), 828-832 (1987).
28. Dolianitis C, Scarff CE, Kelly J, Sinclair R. Iontophoresis with glycopyrrolate for the treatment of palmoplantar hyperhidrosis. Australas J. Dermatol. 45(4), 208-212 (2004).
29. Thomas I, Brown J, Vafaie J, Schwartz RA. Palmoplantar hyperhidrosis: a therapeutic challenge. Am. Fam. Physician. 69(5), 1117-1120 (2004).
30. Bajaj V, Langtry JA. Use of oral glycopyrronium bromide in hyperhidrosis. Br. J. Dermatol. 157(1), 118-121 (2007).
31. Feder R. Clonidine treatment of excessive sweating. J. Clin. Psychiatry 56(1), 35 (1995).
32. Tkach JR. Indomethacin treatment of generalized hyperhidrosis. J. Am. Acad. Dermatol. 6(4 Pt 1), 545 (1982).
33. James WD, Schoomaker EB, Rodman OG. Emotional eccrine sweating. A heritable disorder. Arch. Dermatol. 123(7), 925-929 (1987).
34. Mack GW, Shannon LM, Nadel ER. Infuence of b-adrenergic blockade on the control of sweating in humans. J. Appl. Physiol. 61(5), 1701-1705 (1986).
35. Adams BB, Vargus-Adams JN, Franz DN, Kinnett DG. Hyperhidrosis in pediatric spinal cord injury: a case report and gabapentin therapy. J. Am. Acad. Dermatol. 46(3), 444-446 (2002).
36. Brin MF Botulinum toxin: chemistry, pharmacology, toxicity, and immunology. Muscle Nerve Suppl. 6, S146-S168 (1997).
37. Lowe NJ, Yamauchi PS, Lask GP, Patnaik R, Iyer S. Effcacy and safety of botulinum toxin type a in the treatment of palmar hyperhidrosis: a double-blind, randomized, placebo-controlled study. Dermatol. Surg. 28(9), 822-827 (2002).
38. Naumann M, Lowe NJ. Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: randomized, parallel group, double blind, placebo controlled trial. BMJ 323(7313), 596-599 (2001).
39. Schnider P, Binder M, Kittler H et al. A randomized, double-blind, placebo-controlled trial of botulinum A toxin for severe axillary hyperhidrosis. Br. J. Dermatol. 140(4), 677-680 (1999).
40. Solomon BA, Hayman R. Botulinum toxin type A therapy for palmar and digital hyperhidrosis. J. Am. Acad. Dermatol. 42(6), 1026-1029 (2000).
41. Vadoud-Seyedi J, Simonart T. Treatment of axillary hyperhidrosis with botulinum toxin type A reconstituted in lidocaine or in normal saline: a randomized, side-by-side, double-blind study. Br. J. Dermatol. 156(5), 986-989 (2007).
42. Benohanian A. Needle-free anesthesia: a promising technique for the treatment of palmoplantar hyperhidrosis with botulinum toxin A. Therapy 3(5), 591-596 (2006).
43. Klein AW. Contraindications and complications with the use of botulinum toxin. Clin. Dermatol. 22(1), 66-75 (2004).
44. Lawrence CM, Lonsdale Eccles AA. Selective sweat gland removal with minimal skin excision in the treatment of axillary hyperhidrosis: a retrospective clinical and histological review of 15 patients. Br. J. Dermatol. 155(1), 115-118 (2006).
45. Bechara FG, Gambichler T, Bader A, Sand M, Altmeyer P, Hoffmann K. Assessment of quality of life in patients with primary axillary hyperhidrosis before and after suction-curettage. J. Am. Acad. Dermatol. 57(2), 207-212 (2007).
46. Marhold F, Izay B, Zacherl J, Tschabitscher M, Neumayer C. Thoracoscopic and anatomic landmarks of Kuntz's nerve: implications for sympathetic surgery. Ann. Thorac. Surg. 86(5), 1653-1658 (2008).
47. Boni R. Generalized hyperhidrosis and its systemic treatment. Curr. Probl. Dermatol. 30, 44-47 (2002).
48. Baumgartner FJ, Toh Y. Severe hyperhidrosis: clinical features and current thoracoscopic surgical management. Ann. Thorac. Surg. 76(6), 1878-1883 (2003).
49. Moya J, Ramos R, Morera R et al. Thoracic sympathicolysis for primary hyperhidrosis: a review of 918 procedures. Surg. Endosc. 20(4), 598-602 (2006).
50. Telaranta T. Secondary sympathetic chain reconstruction after endoscopic thoracic sympathicotomy. Eur. J. Surg (Suppl. 580), 17-18 (1998).
51. Lin CC, Mo LR, Lee LS, Ng SM, Hwang MH. Thoracoscopic T2-sympathetic block by clipping-a better and reversible operation for treatment of hyperhidrosis palmaris: experience with 326 cases. Eur. J. Surg (Suppl. 580), 13-16 (1998).
52. Dumont P. Side effects and complications of surgery for hyperhidrosis. Thorac. Surg Clin. 18(2), 193-207 (2008).
53. Chou SH, Kao EL, Lin CC, Chang YT, Huang MF. The importance of classifcation in sympathetic surgery and a proposed mechanism for compensatory hyperhidrosis: experience with 464 cases. Surg. Endosc. 20(11), 1749-1753 (2006).
54. Doolabh N, Horswell S, Williams M et al. Thoracoscopic sympathectomy for hyperhidrosis: indications and results. Ann. Thorac. Surg. 77(2), 410-414; discussion 414 (2004).
55. Licht PB, Pilegaard HK. Severity of compensatory sweating after thoracoscopic sympathectomy. Ann. Thorac. Surg 78(2), 427-431 (2004).
56. Kopelman D, Hashmonai M. The correlation between the method of sympathetic ablation for palmar hyperhidrosis and the occurrence of compensatory hyperhidrosis: a review. World J. Surg. 32(11), 2343-2356 (2008).
57. Katara AN, Domino JP, Cheah WK, So JB, Ning C, Lomanto D. Comparing T2 and T2-T3 ablation in thoracoscopic sympathectomy for palmar hyperhidrosis: a randomized control trial. Surg. Endosc. 21(10), 1768-1771 (2007).
58. Miller DL, Force SD. Outpatient microthoracoscopic sympathectomy for palmar hyperhidrosis. Ann. Thorac. Surg. 83(5), 1850-1853 (2007).
59. Reisfeld R. Sympathectomy for hyperhidrosis: should we place the clamps at T2-T3 or T3-T4? Clin. Auton. Res. 16(6), 384-389 (2006).
60. Cladellas E, Callejas MA, Grimalt R. A medical alternative to the treatment of compensatory sweating. Dermatol. Ther. 21(5), 406-408 (2008).
61. Schick CH, Schick KS, Tarfusser I. Experience with the new ETS classifcation. Presented at: 8th International Sympathetic Surgery Symposium. New York, USA, 26-28 March, 2009.
62. Hafner J, Beer GM. Axillary sweat gland excision. Curr. Probl. Dermatol. 30, 57-63 (2002).
63. Dumont P, Denoyer A, Robin P. Long-term results of thoracoscopic sympathectomy for hyperhidrosis. Ann. Thorac. Surg. 78(5), 1801-1807 (2004).
64. Kim WO, Song Y, Kil HK, Yoon KB, Yoon DM. Suction-curettage with combination of two different cannulae in the treatment of axillary osmidrosis and hyperhidrosis. J. Eur. Acad. Dermatol. Venereol. 22(9), 1083-1088 (2008).
65. Weksler B, Luketich JD, Shende MR. Endoscopic thoracic sympathectomy: at what level should you perform surgery? Thorac. Surg. Clin. 18(2), 183-191 (2008).
66. Ribas Milanez de Campos J, Kauffman P, Wolosker N et al. Axillary hyperhidrosis: T3/T4 versus T4 thoracic sympathectomy in a series of 276 cases. J. Laparoendosc. Adv. Surg. Tech. A. 16(6), 598-603 (2006).
67. Benohanian A Treatment of recalcitrant plantar hyperhidrosis with type-A botulinum toxin injections and aluminum chloride in salicylic acid gel. Dermatol Online J. 14(2), 5 (2008).
68. Baumgartner FJ. Surgical approaches and techniques in the management of severe hyperhidrosis. Thorac. Surg. Clin. 18(2), 167-181 (2008).
69. Kim WO, Yoon KB, Kil HK, Yoon DM. Chemical lumbar sympathetic block in the treatment of plantar hyperhidrosis: a study of 69 patients. Dermatol. Surg 34(10), 1340-1345 (2008).
70. Eisenach JH, Atkinson JL, Fealey RD. Hyperhidrosis: evolving therapies for well-established phenomenon. Mayo Clin. Proc. 80(5) 657-666 (2005).